161 related articles for article (PubMed ID: 37802423)
1. Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis.
Kim H; Jang B; Zhang C; Caldwell B; Park DJ; Kong SH; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2024 Jan; 166(1):117-131. PubMed ID: 37802423
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa.
Min J; Zhang C; Bliton RJ; Caldwell B; Caplan L; Presentation KS; Park DJ; Kong SH; Lee HS; Washington MK; Kim WH; Lau KS; Magness ST; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2022 Oct; 163(4):875-890. PubMed ID: 35700772
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in Gastric Carcinogenesis.
Won Y; Jang B; Lee SH; Reyzer ML; Presentation KS; Kim H; Caldwell B; Zhang C; Lee HS; Lee C; Trinh VQ; Tan MCB; Kim K; Caprioli RM; Choi E
Gastroenterology; 2024 May; 166(5):772-786.e14. PubMed ID: 38272100
[TBL] [Abstract][Full Text] [Related]
4. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
[TBL] [Abstract][Full Text] [Related]
5. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
6. Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer.
Feng J; Jiang W; Liu Y; Huang W; Hu K; Li K; Chen J; Ma C; Sun Z; Pang X
Biochem Pharmacol; 2020 Jul; 177():113960. PubMed ID: 32298693
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach.
Min J; Vega PN; Engevik AC; Williams JA; Yang Q; Patterson LM; Simmons AJ; Bliton RJ; Betts JW; Lau KS; Magness ST; Goldenring JR; Choi E
Nat Commun; 2019 Dec; 10(1):5549. PubMed ID: 31804471
[TBL] [Abstract][Full Text] [Related]
8. Dynamic tuft cell expansion during gastric metaplasia and dysplasia.
Jang B; Kim H; Lee SH; Won Y; Kaji I; Coffey RJ; Choi E; Goldenring JR
J Pathol Clin Res; 2024 Jan; 10(1):e352. PubMed ID: 38117182
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.
Chung WC; Zhou Y; Atfi A; Xu K
Neoplasia; 2019 Aug; 21(8):810-821. PubMed ID: 31276933
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.
Okumura T; Ericksen RE; Takaishi S; Wang SS; Dubeykovskiy Z; Shibata W; Betz KS; Muthupalani S; Rogers AB; Fox JG; Rustgi AK; Wang TC
Cancer Res; 2010 Nov; 70(21):8435-45. PubMed ID: 20959488
[TBL] [Abstract][Full Text] [Related]
11. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.
Shi G; DiRenzo D; Qu C; Barney D; Miley D; Konieczny SF
Oncogene; 2013 Apr; 32(15):1950-8. PubMed ID: 22665051
[TBL] [Abstract][Full Text] [Related]
13. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
14. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.
Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y
Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.
Bockerstett KA; Lewis SA; Noto CN; Ford EL; Saenz JB; Jackson NM; Ahn TH; Mills JC; DiPaolo RJ
Gastroenterology; 2020 Dec; 159(6):2116-2129.e4. PubMed ID: 32835664
[TBL] [Abstract][Full Text] [Related]
17. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
[TBL] [Abstract][Full Text] [Related]
18. A Point Mutation R122C in RUNX3 Promotes the Expansion of Isthmus Stem Cells and Inhibits Their Differentiation in the Stomach.
Douchi D; Yamamura A; Matsuo J; Lee JW; Nuttonmanit N; Melissa Lim YH; Suda K; Shimura M; Chen S; Pang S; Kohu K; Kaneko M; Kiyonari H; Kaneda A; Yoshida H; Taniuchi I; Osato M; Yang H; Unno M; Bok-Yan So J; Yeoh KG; Chuang LSH; Bae SC; Ito Y
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1317-1345. PubMed ID: 35074568
[TBL] [Abstract][Full Text] [Related]
19. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract][Full Text] [Related]
20. NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations.
Park E; Park J; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Int J Oncol; 2012 Apr; 40(4):1259-66. PubMed ID: 22159814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
